In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arrow: Focus and Flexibility

Executive Summary

In October 2003, infectious diseases start-up Arrow Therapeutics' £21 million funding round from four new international VCs and five existing backers topped the ranks of UK biotech fundraisings. The round shows that investors value a broad pipeline, plus well-connected management able to balance focus with opportunism, more than a product in the clinic or a sexy new technology.
Advertisement

Related Content

Antibacterials: Biotechs Fill the Big Pharma Void
More Funding Options for European biotech
Athelas Ltd.
QSI Pharma AS
GeneSoft: The Value of Compromised Products
Antibiotics: Start-Ups Ply Novel Targets and Technologies
Versicor/Biosearch Italia: Merging as Equals
The FDA and Antibiotics: An Unsettled Agency of Many Minds
Cubist: The Virtues of Pipeline Diversification
Arrow Therapeutics

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel